Midkine and its clinical significance in endometrial carcinoma

作者: Kojiro Tanabe , Mitsuyo Matsumoto , Shinya Ikematsu , Satoru Nagase , Atsushi Hatakeyama

DOI: 10.1111/J.1349-7006.2008.00796.X

关键词:

摘要: Midkine (MK) is a secreted heparin-binding growth factor. Several types of human cancer have increased MK expression with elevated serum levels. The purpose this study was to determine whether expressed in endometrial carcinoma and evaluate the clinicopathological significance patients carcinoma. Immunohistochemical evaluated 85 samples 33 controls. significantly higher carcinomas than normal endometrium (P < 0.001). Interestingly, highest at margins invasion low superficial areas tumor samples. Using ELISA, we compared concentration 120 46 benign gynecologic tumors. Serum value that diseases = 0.01). Patients positive lymph node metastasis or recurrence, death, had level 0.008, P 0.009, respectively). In conclusion, immunoreactivity endometrium. Additionally, preoperative levels are correlated prognosis presence metastasis. Thus, may be useful biomarker for identifying high risk

参考文章(34)
Michikawa M, Sanjo N, Mizusawa H, Owada K, Muramatsu H, Kobayashi T, Muramatsu T, Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. Journal of Neurochemistry. ,vol. 73, pp. 2084- 2092 ,(1999)
M. Qi, S. Ikematsu, K. Icbihara-Tanaka, S. Sakuma, T. Muramatsu, K. Kadomatsu, Midkine Rescues Wilms, Tumor Cells from Cisplatin-Induced Apoptosis: Regulation of Bcl-2 Expression by Midkine Journal of Biochemistry. ,vol. 127, pp. 269- 277 ,(2000) , 10.1093/OXFORDJOURNALS.JBCHEM.A022604
Garrett M. Brodeur, Jeffrey Milbrandt, Huaqing Zhao, Akira Nakagawara, Thomas F. Deuel, Takashi Muramatsu, Avital Cnaan, Differential Expression of Pleiotrophin and Midkine in Advanced Neuroblastomas Cancer Research. ,vol. 55, pp. 1792- 1797 ,(1995)
Sandra Donnini, Rangana Choudhuri, Roy Bicknell, Marina Ziche, Hua-Tang Zhang, An Angiogenic Role for the Neurokines Midkine and Pleiotrophin in Tumorigenesis Cancer Research. ,vol. 57, pp. 1814- 1819 ,(1997)
Jo Vandesompele, Katleen De Preter, Filip Pattyn, Bruce Poppe, Nadine Van Roy, Anne De Paepe, Frank Speleman, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biology. ,vol. 3, pp. 1- 12 ,(2002) , 10.1186/GB-2002-3-7-RESEARCH0034
Susan Fuggle, Roy Bicknell, David Cranston, Tim O'Brien, Adrian L. Harris, The Angiogenic Factor Midkine Is Expressed in Bladder Cancer, and Overexpression Correlates with a Poor Outcome in Patients with Invasive Cancers Cancer Research. ,vol. 56, pp. 2515- 2518 ,(1996)
Ying-Jia Ren, Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World Journal of Gastroenterology. ,vol. 12, pp. 2006- 2010 ,(2006) , 10.3748/WJG.V12.I13.2006
Robert I. Garver, Christine S. Chan, Peter G. Milner, Reciprocal Expression of Pleiotrophin and Midkine in Normal Versus Malignant Lung Tissues American Journal of Respiratory Cell and Molecular Biology. ,vol. 9, pp. 463- 466 ,(1993) , 10.1165/AJRCMB/9.5.463
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M. J. Thun, Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. ,vol. 57, pp. 43- 66 ,(2007) , 10.3322/CANJCLIN.57.1.43
Hideaki Shimada, Yoshihiro Nabeya, Masatoshi Tagawa, Shin-ichi Okazumi, Hisahiro Matsubara, Kenji Kadomatsu, Takashi Muramatsu, Shinya Ikematsu, Sadatoshi Sakuma, Takenori Ochiai, Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma Cancer Science. ,vol. 94, pp. 628- 632 ,(2003) , 10.1111/J.1349-7006.2003.TB01494.X